• Nenhum resultado encontrado

neoadjuvant chemotherapy

Accuracy of contrast-enhanced spectral mammography for estimating residual tumor size after neoadjuvant chemotherapy in patients with breast cancer: a feasibility study

Accuracy of contrast-enhanced spectral mammography for estimating residual tumor size after neoadjuvant chemotherapy in patients with breast cancer: a feasibility study

... Accuracy of contrast-enhanced spectral mammography for estimating residual tumor size after neoadjuvant chemotherapy in patients with breast cancer: a feasibility study.. 2017 Jul/Ago;5[r] ...

8

Young Cervical Cancer Patients May Be More Responsive than Older Patients to Neoadjuvant Chemotherapy Followed by Radical Surgery.

Young Cervical Cancer Patients May Be More Responsive than Older Patients to Neoadjuvant Chemotherapy Followed by Radical Surgery.

... to neoadjuvant chemo- therapy between young and older patients, and no prospective study has focused solely on the outcomes of neoadjuvant chemotherapy in young patients ...

11

Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.

Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.

... after neoadjuvant chemotherapy, and a median of 9% and 36% had complete or partial pathological responses, respectively, whereas 41% had stable or progressive disease while receiving neoadjuvant ...

6

Marked cytoreduction of a lymphocyte-rich mediastinal thymoma with neoadjuvant chemotherapy in a cat

Marked cytoreduction of a lymphocyte-rich mediastinal thymoma with neoadjuvant chemotherapy in a cat

... The marked reduction in size of the thymoma in this case following neoadjuvant chemotherapy was unusual and therefore unexpected. As an optimal chemothera- peutic protocol for thymoma in dogs and cats has ...

7

Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors

Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors

... with chemotherapy in the treatment of patients with early operable and metastatic HER2-positive breast cancer ...the neoadjuvant setting, when associated with chemotherapy, trastuzumab significantly ...

6

HLA-DR in Cytotoxic T lymphocytes predicts breast cancer patients' response to neoadjuvant chemotherapy

HLA-DR in Cytotoxic T lymphocytes predicts breast cancer patients' response to neoadjuvant chemotherapy

... Prediction of breast cancer response to Neoadjuvant Chemotherapy (NACT) is an urgent need to promptly direct non-responder patients to alternative therapies. Infiltrating T lymphocytes, namely cytotoxic T ...

14

The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer.

The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer.

... Methodology/Principal Findings: Tumor biopsies were obtained from 86 breast cancer patients who were candidates for neoadjuvant chemotherapy, treated with four cycles of neoadjuvant fluorouracil, ...

9

Computed tomography (CT) perfusion as an early predictive marker for treatment response to neoadjuvant chemotherapy in gastroesophageal junction cancer and gastric cancer--a prospective study.

Computed tomography (CT) perfusion as an early predictive marker for treatment response to neoadjuvant chemotherapy in gastroesophageal junction cancer and gastric cancer--a prospective study.

... preoperative chemotherapy for adenocarcinomas in the esophagus and at the gastroesophageal ...neoadjuvant chemotherapy. The MUNICON-1 trial [38] indicated that chemotherapy can be discontinued ...

10

Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.

Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.

... post- neoadjuvant chemotherapy ADC values were significantly higher than the pre- neoadjuvant chemotherapy values both in patients with good response and poor ...post- neoadjuvant ...

7

Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based Study.

Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based Study.

... Neoadjuvant chemotherapy (NCT) administered prior to definitive surgical resection is rec- ommended as the standard of care in locally advanced breast ...the neoadjuvant setting has yet to be ...

13

Obesity or overweight is associated with worse pathological response to neoadjuvant chemotherapy among Chinese women with breast cancer.

Obesity or overweight is associated with worse pathological response to neoadjuvant chemotherapy among Chinese women with breast cancer.

... especially chemotherapy, remains controversial. Neoadjuvant chemotherapy trials may act as a possible approach to address this ...of neoadjuvant chemotherapy because patients with pCR ...

7

Prognostic and Predictive Significance of MYC and KRAS Alterations in Breast Cancer from Women Treated with Neoadjuvant Chemotherapy

Prognostic and Predictive Significance of MYC and KRAS Alterations in Breast Cancer from Women Treated with Neoadjuvant Chemotherapy

... for chemotherapy response in ...to neoadjuvant chemotherapy comprising paclitaxel followed by 5-FU/epirubicin/cyclophosphamide by univariate ...with chemotherapy (cyclophosphamide, ...

9

The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

... adjuvant chemotherapy for treatment of these patients are insuicient, neoadjuvant chemotherapy (NAC) that includes cisplatin-based combination therapy for MIBC is recommended by the ...

6

Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer

Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer

... Table 1 shows individual data such as patient age, histological diagnosis, grade of nuclear differentiation, clini- cal and pathological staging, and response to neoadjuvant chemotherapy. All breast cancer ...

9

Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapy.

Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapy.

... The purpose of this study was to determine whether metabolic profiling of core needle biopsy (CNB) samples using high-resolution magic angle spinning (HR-MAS) magnetic resonance spectroscopy (MRS) could be used for ...

10

Response prediction to neoadjuvant chemotherapy: comparison between pre-therapeutic gene expression profiles and in vitro chemosensitivity assay.

Response prediction to neoadjuvant chemotherapy: comparison between pre-therapeutic gene expression profiles and in vitro chemosensitivity assay.

... following neoadjuvant chemotherapy is seen in 3–26% of patients, and is a good predictor of survival ...of neoadjuvant regimen do not achieve pCR, tumors can still respond in a clinically meaningful ...

8

DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis.

DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis.

... of tumor-expressing cells, and reported according to a scale of 0 to 8. Tumors were classified as low expressing if the Allred score was  2 (pWee1 allred low , pChk1 allred low ), or as high expressing if the Allred ...

11

Neoadjuvant chemotherapy making a pancreatic head cancer resectable.

Neoadjuvant chemotherapy making a pancreatic head cancer resectable.

... 3. White RR, Hurwitz HI, Morse MA, Lee C, Anscher MS, Paulson EK, Gottfried MR, Baillie J, Branch MS, Jowell PS, McGrath KM, Clary BM, Pappas TN, Tyler DS. Neoadjuvant chemoradiation for localized adenocarcinoma ...

2

Int. braz j urol.  vol.36 número1

Int. braz j urol. vol.36 número1

... America neoadjuvant chemotherapy before radical cystectomy became standard few years ...deliver chemotherapy) refuse radical cystectomy if a complete response is found in the bladder? This paper ...

2

Rev. Col. Bras. Cir.  vol.40 número3

Rev. Col. Bras. Cir. vol.40 número3

... of neoadjuvant chemotherapy (Table 2), as well as increase in the number of mastectomies performed by the Mastology Program (Table 2 and Figure 1), unlike the breast conservative treatment, which remained ...

6

Show all 446 documents...

temas relacionados